Flec-SL: short- vs. long-term flecainide after AF cardioversion

The goal of antiarrhythmic therapy following cardioversion for atrial fibrillation (AF) is to prevent further recurrences for as long as possible.  However, it is known that the atrial action potential normalises after 2-4 weeks of sinus rhythm, suggesting that drugs may not be essential in the long-term.  The goal of this study was to investigate […]

Read More…